Income Taxes (Details) - DIAMIR BIOSCIENCES CORP. [Member] - USD ($) |
12 Months Ended | |
|---|---|---|
May 31, 2025 |
May 31, 2024 |
|
| Income Taxes (Details) [Line Items] | ||
| Net operating loss | $ 1,541,000 | $ 1,047,000 |
| Net operating loss state | 392,000 | 392,000 |
| Net operating loss | $ 165,000 | |
| Future taxable income | 80.00% | |
| Valuation allowance increase | $ 104,071 | 181,606 |
| Accrued interest or penalties | $ 20,483 | $ 4,000 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Percentage of future taxable income. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|